Global Custom Market Research Reports Provider Company

phone

Tasly Pharmaceutical Group Co Ltd (600535) - Financial and Strategic SWOT Analysis Review

  • Published Date: 03 Jan 2019
  • Number of Pages: 37
  • Category: SWOT Analysis
  • Country: China
Tasly Pharmaceutical Group Co Ltd (600535) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Tasly Pharmaceutical Group Co Ltd (Tasly), formerly Tianjin Tasly Pharmaceutical Co., Ltd., manufactures and distributes chemical medicine, biological medicine, healthcare products, traditional Chinese medicine (TCM), functional food and other products. The companys product line includes herbal medicine, chemical medicine, health product, pharmaceutical substances and active pharmaceutical ingredients (APIs), herbal extract, tea, cosmetics, daily hygiene product series and medical equipment. It markets its products in domestic market through its own sales force and through distributors and subsidiaries in Malaysia, Indonesia, Vietnam, South Korea, Pakistan, Thailand, Istanbul, Botswana, South Africa, Ghana, Kenya, Zambia, Nigeria, Russia, Netherlands, Bahamas and the US. Tasly is headquartered in Tianjin, China.

Tasly Pharmaceutical Group Co Ltd Key Recent Developments

Sep 17,2018: TOPC : Tasly Pharmaceutical Group Receives All Necessary Approvals for Transaction With Mesoblast[Newswire : MarketLine - GNW]

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData


List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Tasly Pharmaceutical Group Co Ltd - Key Facts 5
Tasly Pharmaceutical Group Co Ltd - Key Employees 6
Tasly Pharmaceutical Group Co Ltd - Major Products and Services 7
Tasly Pharmaceutical Group Co Ltd - History 10
Tasly Pharmaceutical Group Co Ltd - Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Joint Venture 12
Section 2 Company Analysis 13
Company Overview 13
Tasly Pharmaceutical Group Co Ltd - Business Description 14
Tasly Pharmaceutical Group Co Ltd - Corporate Strategy 16
Tasly Pharmaceutical Group Co Ltd - SWOT Analysis 17
SWOT Analysis - Overview 17
Tasly Pharmaceutical Group Co Ltd - Strengths 17
Tasly Pharmaceutical Group Co Ltd - Weaknesses 18
Tasly Pharmaceutical Group Co Ltd - Opportunities 19
Tasly Pharmaceutical Group Co Ltd - Threats 20
Tasly Pharmaceutical Group Co Ltd - Key Competitors 21
Section 3 Company Financial Ratios 22
Financial Ratios - Capital Market Ratios 22
Financial Ratios - Annual Ratios 23
Performance Chart 26
Financial Performance 26
Financial Ratios - Interim Ratios 27
Financial Ratios - Ratio Charts 28
Section 4 Companys Lifesciences Financial Deals and Alliances 29
Tasly Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 29
Tasly Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 30
Tasly Pharmaceutical Group Co Ltd, Recent Deals Summary 31
Section 5 Companys Recent Developments 32
Sep 17, 2018: TOPC : Tasly Pharmaceutical Group Receives All Necessary Approvals for Transaction With Mesoblast[Newswire : MarketLine - GNW] 32
Section 6 Appendix 33
Methodology 33
Ratio Definitions 33
About GlobalData 37
Contact Us 37
Disclaimer 37

List Of Tables


Tasly Pharmaceutical Group Co Ltd, Key Facts 5
Tasly Pharmaceutical Group Co Ltd, Key Employees 6
Tasly Pharmaceutical Group Co Ltd, Major Products and Services 7
Tasly Pharmaceutical Group Co Ltd, History 10
Tasly Pharmaceutical Group Co Ltd, Subsidiaries 12
Tasly Pharmaceutical Group Co Ltd, Joint Venture 12
Tasly Pharmaceutical Group Co Ltd, Key Competitors 21
Tasly Pharmaceutical Group Co Ltd, Ratios based on current share price 22
Tasly Pharmaceutical Group Co Ltd, Annual Ratios 23
Tasly Pharmaceutical Group Co Ltd, Annual Ratios (Cont...1) 24
Tasly Pharmaceutical Group Co Ltd, Annual Ratios (Cont...2) 25
Tasly Pharmaceutical Group Co Ltd, Interim Ratios 27
Tasly Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 29
Tasly Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 30
Tasly Pharmaceutical Group Co Ltd, Recent Deals Summary 31
Currency Codes 33
Capital Market Ratios 33
Equity Ratios 34
Profitability Ratios 34
Cost Ratios 35
Liquidity Ratios 35
Leverage Ratios 36
Efficiency Ratios 36

List Of Figures


Tasly Pharmaceutical Group Co Ltd, Performance Chart (2013 - 2017) 26
Tasly Pharmaceutical Group Co Ltd, Ratio Charts 28
Tasly Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 29
Tasly Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019 30

There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports